# DeepEyeVision

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/deepeyevision

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: https://deepeyevision.com
- Latest round: Seed (Feb 5, 2020)
- Investors on record: 2

## About

DeepEyeVision Inc. develops AI-driven medical devices aimed at enhancing ophthalmological diagnostics. Their innovative solutions leverage deep learning technology to improve diagnostic accuracy for eye care patients, particularly as the population ages.Founded in 2016 in Tokyo, Japan, DeepEyeVision Inc. specializes in AI-based medical diagnostics for ophthalmology. With a focus on enhancing diagnostic processes, the company has successfully completed 2 deals to date, with the most recent deal occurring on November 29, 2024.DeepEyeVision???? specializes in developing AI-driven medical devices focused on ophthalmology, particularly leveraging deep learning technologies. Their core offerings aim to enhance diagnostic accuracy for an increasing number of eye care patients, driven by the aging population. By integrating advanced image analysis capabilities, their solutions support healthcare professionals in providing precise diagnostic assistance across various ocular conditions. The company primarily serves hospitals and ophthalmology clinics across Japan, catering to both medical practitioners and their patients, who benefit from improved diagnostic efficiency and treatment outcomes.The revenue model of DeepEyeVision revolves around B2B transactions, primarily involving partnerships with healthcare institutions that integrate their AI-based diagnostic tools into their practices. These transactions typically involve licensing agreements or subscription-based models, allowing clients to utilize the technology for a specified period while receiving ongoing support and updates. Specific pricing plans for their flagship products and services are structured to reflect the value provided to healthcare providers, with costs designed to ensure accessibility and encourage widespread adoption within the ophthalmology sector. Overall, the company’s revenue generation strategy emphasizes long-term relationships with medical facilities, fostering continual usage of their innovative diagnostic solutions.In November 2024, DeepEyeVision Inc. raised an undisclosed amount of venture funding from Japan Medical Company Inc. The investment aims to enhance AI-driven medical diagnostics, improve healthcare quality, and support innovation in medical technology and services. The company is actively designing new products to be launched in the coming year and plans to expand its market presence beyond Japan into Southeast Asia by 2025.

## Funding rounds

- Seed, Feb 5, 2020 — Deepcore, INDEE Japan

## Investors

- Deepcore (https://capitalatlas.ai/funds/deepcore) — Seed
- INDEE Japan — Seed